(Total Views: 314)
Posted On: 03/25/2022 1:43:41 PM
Post# of 8390
>>>I don't know about anybody else but I get the feeling that whatever next week's financials bring there is something brewing vis-a-vis RecoveryRx. Way too many data points. Lots of emphasis on RRx being 'prescription only<<<
I agree! And as I have expressed numerous times, RecoveryRX could be the sleeper success in all of Bioelectronic products. Sales worldwide are exclusively from Bioelectronics. Charging a higher price than Actipatch, no cutting up the profits and no exclusive deals with another seller (ie KT Tape). Not to mention if the product gets insurance coverage cleared! And I see no reason why it shouldn't when used post operative.
YES, things are getting very interesting and I am going nowhere but HERE, to see this ALL materialize!!!
I agree! And as I have expressed numerous times, RecoveryRX could be the sleeper success in all of Bioelectronic products. Sales worldwide are exclusively from Bioelectronics. Charging a higher price than Actipatch, no cutting up the profits and no exclusive deals with another seller (ie KT Tape). Not to mention if the product gets insurance coverage cleared! And I see no reason why it shouldn't when used post operative.
YES, things are getting very interesting and I am going nowhere but HERE, to see this ALL materialize!!!
(1)
(0)
